Business Context and Reporting Period
Company: Metropolitan Bank Holding Corp. (MCB)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended September 30, 2025
Business Overview: A New York-based bank holding company operating through Metropolitan Commercial Bank. The Company focuses on commercial real estate (CRE), multi-family, and commercial and industrial (C&I) lending, primarily in the New York metropolitan area and South Florida. It exited its Global Payments Group (GPG) Banking-as-a-Service business in 2024.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Income | $7.1 million | $12.3 million | $42.2 million | $45.3 million |
| Diluted EPS | $0.67 | $1.08 | $3.89 | $4.04 |
| Net Interest Income | $77.3 million | $65.2 million | $217.9 million | $186.5 million |
| Net Interest Margin (NIM) | 3.88% | 3.62% | 3.80% | 3.49% |
| Provision for Credit Losses | $23.9 million | $2.7 million | $34.7 million | $4.8 million |
| Total Assets | $8.23 billion | N/A | N/A | N/A |
| Total Loans (Net) | $6.69 billion | N/A | N/A | N/A |
| Total Deposits | $7.07 billion | N/A | N/A | N/A |
| Cash & Equivalents | $385.9 million | N/A | N/A | N/A |
| Stockholders' Equity | $732.0 million | N/A | N/A | N/A |
Material Changes vs. Prior Period
- Profitability Decline: Net income decreased 42% year-over-year in Q3 2025. This was driven primarily by a $21.2 million increase in the provision for credit losses and the absence of $3.5 million in GPG revenue, partially offset by a $12.1 million increase in net interest income.
- Asset Growth: Total assets increased 12.8% to $8.23 billion from year-end 2024. Total loans grew 12.4% to $6.69 billion, driven by a $752.7 million increase in CRE loans. Total deposits surged 18.2% to $7.07 billion.
- Asset Quality Deterioration: Non-performing loans (NPLs) more than doubled to $81.6 million (1.20% of total loans) from $32.6 million at year-end 2024. This increase is attributed to a single out-of-market CRE multi-family loan relationship and a single secured CRE loan.
- Allowance for Credit Losses (ACL): The ACL increased to $94.2 million (1.39% of total loans) from $63.3 million at year-end 2024, reflecting the specific credit issues noted above and macroeconomic outlook adjustments.
- Cost of Funds: The total cost of funds decreased to 3.05% in Q3 2025 from 3.39% in Q3 2024, reflecting lower short-term interest rates.
Guidance, Outlook, and Risks
- Capital Actions: The Board authorized an additional $50 million share repurchase plan in July 2025 (totaling $100 million authorized since March 2025). As of September 30, 2025, $47.3 million remained available. A quarterly dividend of $0.15 per share was declared on October 21, 2025.
- Leadership Change: Anthony J. Fabiano was elected independent Chairman of the Board on September 30, 2025.
- Interest Rate Risk: The Company maintains a controlled assumption of interest rate risk. Simulations indicate that a 200 basis point increase in rates would decrease net interest income by 0.13%, while a 200 basis point decrease would increase it by 1.86%.
- Legal and Regulatory: The Company has resolved investigations regarding its former GPG prepaid debit card program with the FRB, NYSDFS, and the Washington Attorney General. Management does not expect pending legal matters to be material to financial condition.
- Concentration Risk: The healthcare industry represents 40.9% of the total loan portfolio ($2.8 billion), with skilled nursing facilities comprising the majority. Non-owner-occupied CRE loans were 373.5% of risk-based capital at period end.
Investor Verification Checklist
- Credit Quality Specifics: Verify the details and collateral coverage of the specific out-of-market CRE multi-family loan and secured CRE loan driving the spike in non-performing assets and the $34.7 million provision.
- Deposit Stability: Assess the composition of the $1.1 billion deposit growth, specifically the mix of uninsured deposits ($1.8 billion total) and the reliance on money market accounts.
- CRE Concentration: Review the exposure to the healthcare/skilled nursing sector (40.9% of loans) and the impact of the high CRE-to-capital ratio (373.5%) on regulatory capital buffers.
- Revenue Mix: Confirm the trajectory of non-interest income post-GPG exit and the sustainability of the improved Net Interest Margin (3.88%) in a falling rate environment.
- Liquidity Position: Validate the $3.2 billion available secured wholesale funding capacity and the encumbrance status of the $798.7 million securities pledged.